{"title":"CDC greenlights RSV vaccine during pregnancy—but only for seasonal use","link":"https://arstechnica.com/?p=1970620","date":1695423206000,"content":"<div>\n<figure>\n  <img src=\"https://cdn.arstechnica.net/wp-content/uploads/2022/11/GettyImages-1236879418-800x531.jpeg\" alt=\"An intensive care nurse cares for a patient suffering from respiratory syncytial virus (RSV), who is being ventilated in the children's intensive care unit of the Olga Hospital of the Stuttgart Clinic in Germany.\" />\n      <p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2022/11/GettyImages-1236879418-scaled.jpeg\">Enlarge</a> <span>/</span> An intensive care nurse cares for a patient suffering from respiratory syncytial virus (RSV), who is being ventilated in the children's intensive care unit of the Olga Hospital of the Stuttgart Clinic in Germany. (credit: <a href=\"https://www.gettyimages.com/detail/news-photo/november-2021-baden-wuerttemberg-stuttgart-an-intensive-news-photo/1236879418?phrase=RSV&amp;adppopup=true\">Getty | picture alliance</a>)</p>  </figure>\n\n\n\n\n\n\n<div><a name=\"page-1\"></a></div>\n<p><a href=\"https://arstechnica.com/science/2022/11/why-pfizers-rsv-vaccine-success-is-a-big-deal-decades-in-the-making/\">A Pfizer vaccine</a> designed to protect newborns and infants from severe RSV illness won a recommendation from the Centers for Disease Control and Prevention Friday—but only for seasonal use.</p>\n<p>The vaccine is Pfizer’s bivalent RSVpreF vaccine, called Abrysvo, and is administered to pregnant people late in gestation, between 32 and 36 weeks.</p>\n<p>RSV, or respiratory syncytial (sin-SISH-uhl) virus, is the leading cause of hospitalization for infants in the US. Each year, 1.5 million children seek out-patient care for RSV, with 58,000 to 80,000 ending up in the hospital and 100 to 300 tragically dying from the infection.</p></div><p><a href=\"https://arstechnica.com/?p=1970620#p3\">Read 8 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=1970620&amp;comments=1\">Comments</a></p>","author":"Beth Mole","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"c8debfbbe51f259b0e7cc404462b2c66682b2ed2d4306391e2a5467ea46b851a","category":"Tech"}